Condition 1: Ischemic Heart Disease. Condition 2: Ischemic Heart Disease. Condition 3: Ischemic Heart Disease. Angina pectoris Other acute ischaemic heart diseases Chronic ischaemic heart disease
Conditions
Interventions
Intervention 1: Interventional group: submaximal exercise upto 3 minutes at phase 1 of Bruce protocol using tredmil in addition to conventional pharmacological stress. Intervention 2: Control group:
Treatment - Drugs
Interventional group: submaximal exercise upto 3 minutes at phase 1 of Bruce protocol using tredmil in addition to conventional pharmacological stress
Control group: Conventional pharmacological stress alone
Sponsors
Deputy of Research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 149 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age more than 20 years; non-pregnant; non-breast feeding (for female patients); intermediate pretest probability of coronary artery disease on the basis of Framingham Risk Score and Exclusion criteria: Asthma; chronic renal failure; left bundle branch block; severe AV block; Irregularly cardiac arrythmia; pacemaker; disability to perfom submaximal exercise; congestive heart failure with EF<15%; hepatic insufficiency; cholestasis; severe aortic stenosis; patient refusal to cooperate.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Myocardial to liver activity ratio. Timepoint: 15, 60, 120 and 180 minutes after radiotracer injection. Method of measurement: Reconstruction software of SPECT.;Myocardial to colon (splenic curve) activity ratio. Timepoint: 15, 60, 120 and 180 minutes after radiotracer injection. Method of measurement: Reconstruction software of SPECT. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Babak Fallahi
Research Institute for Nuclear Medicine, Tehran University of Medical Sciences
Outcome results
None listed